期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 116, 期 11, 页码 3060-3069出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI27341
关键词
-
Alzheimer's disease (AD) is characterized by progressive neurodegeneration and cerebral accumulation of the P-amyloid peptide (A beta), but it is unknown what makes neurons susceptible to degeneration. We report that the TGF-beta type II receptor (T beta RII) is mainly expressed by neurons, and that T beta RII levels are reduced in human AD brain and correlate with pathological hallmarks of the disease. Reducing neuronal TGF-beta signaling in mice resulted in age-dependent neurodegeneration and promoted A beta accumulation and dendritic loss in a mouse model of AD. In cultured cells, reduced TGF-beta signaling caused neuronal degeneration and resulted in increased levels of secreted A beta and beta-secretase-cleaved soluble amyloid precursor protein. These results show that reduced neuronal TGF-beta signaling increases age-dependent neurodegeneration and AD-like disease in vivo Increasing neuronal TGF-beta signaling may thus reduce neurodegeneration and be beneficial in AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据